Efficacy of Radicava® IV (intravenous Edaravone) in Subjects with Differing Trajectories of Disease Progression in Amyotrophic Lateral Sclerosis: Use of a Novel Statistical Approach for Post Hoc Analysis of a Pivotal Phase 3 Clinical Trial